BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2008
View Archived Issues
Recent Japanese patents describe new agents for endocrine-related disorders
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
New immmunosuppressants for preventing transplant rejection reported in recent Rigel patent
Read More
Hsp90 inhibitor MPC-3100 active in tumor models
Read More
PROTECT-1: 45% clinical remission rate with CCX-282-B in Crohn's disease patients
Read More
Parion and Kainos sign clinical development agreement for dry mouth treatment P-552
Read More
Allergan and Spectrum collaborate on apaziquone development
Read More
Phase I data on Millennium's Aurora A kinase inhibitors available
Read More
GlaxoSmithKline to acquire Genelabs Technologies
Read More
Radezolid and linezolid equally effective in uncomplicated skin and skin structure infections
Read More
DAC initiates phase I/IIa clinical trial of DAC-0060 in non-melanoma skin cancers
Read More
Lpath and Merck Serono sign worldwide license agreement for ASONEP monoclonal antibody
Read More
Alvine reports results from phase I clinical trial of ALV-003 in celiac disease
Read More
Nabi reports final results from phase II immunogenicity study of NicVAX
Read More
Snapshots: ACCESS, CHARM, CARE results for adalimumab in Crohn's disease
Read More
Preclinical data on D-3263 show anticancer potential of TrpM8 agonism
Read More
SuperGen reports on development of JAK2 inhibitor SGI-1252
Read More
Karo's phase II study expands the potential for eprotirome in dyslipidemia
Read More
Morria presents preliminary results from phase II allergic rhinitis study
Read More
Telik reports top-line results from Assist-5 trial in ovarian cancer
Read More
Infinity expands phase II study of IPI-504 in advanced non-small cell lung cancer
Read More
Takeda submits NDA for Actos combination tablet in Japan
Read More
FDA accepts for priority review ImClone and Bristol-Myers' sBLA for Erbitux
Read More
FDA grants orphan drug status to Aldagen's ALD-101 stem cell therapy
Read More
Patient enrollment complete in RES-ELUTION I trial of Cordis and Conor Medsytems' Nevo stent
Read More